Literature DB >> 70433

Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins.

D R Phillips, P P Agin.   

Abstract

Platelets from patients with Glanzmann's thrombasthenia have a distinct molecular alteration of the plasma membrane surface, namely decreased amounts of a major glycoprotein designated as IIb (apparent mol wt 142,000). To identify other possible surface defects of thrombasthenic platelets, we labeled the membrane polypeptides of normal and thrombasthenic platelets by two different techniques: lactoperoxidase-catalyzed iodination and galactose oxidase oxidation, followed by reduction with tritiated sodium borohydride. Labeling patterns were determined after the polypeptides were separated by two-dimensional polyacrylamide gel electrophoresis. Before the second dimension was run, platelet samples were incubated with a reducing agent, beta-mercapto-ethanol, to cleave the disulfide bonds of certain glycoproteins; the resulting changes in electrophoretic mobility permitted better resolution of individual molecules. Comparison of the labeled polypeptides of normal and thrombasthenic samples after reduction indicated decreased labeling of two major glycoproteins in thrombasthenic platelets: IIb and III (apparent mol wt 114,000). The relative proportions of radioactivity incorporated by these polypeptides were about 60 and 80% less than control values, respectively. With either Coomassie Blue or periodic acid-Schiff's reagent, glycoprotein III stained much less intensely in thrombasthenic compared to normal samples, indicating that the observed labeling deficit was caused by a decreased concentration of the molecule rather than steric inaccessibility on the membrane surface. Analysis of normal plasma membranes by affinity chromatography showed that glycoprotein IIb has receptors for lectin from Lens culinaris, the common lentil, whereas III does not. We conclude that a characteristic feature of Glanzmann's thrombasthenia is a decreased concentration of two discrete glycoproteins in the platelet plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70433      PMCID: PMC372398          DOI: 10.1172/JCI108805

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

Review 1.  Platelet physiology and abnormalities of platelet function (second of two parts).

Authors:  H J Weiss
Journal:  N Engl J Med       Date:  1975-09-18       Impact factor: 91.245

2.  Effects of ADP and ATP on bovine fibrinogen- and ristocetin-induced platelet aggregation in Glanzmann's thrombasthenia.

Authors:  I Cohen; T Glaser; U Seligsohn
Journal:  Br J Haematol       Date:  1975-11       Impact factor: 6.998

3.  Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes.

Authors:  D R Phillips; C S Jenkins; E F Lüscher; M Larrieu
Journal:  Nature       Date:  1975-10-16       Impact factor: 49.962

4.  Specific roles for platelet surface glycoproteins in platelet function.

Authors:  A T Nurden; J P Caen
Journal:  Nature       Date:  1975-06-26       Impact factor: 49.962

5.  THE CORRECTION OF PROLONGED BLEEDING TIMES IN TWO BROTHERS BY PLATELET TRANSFUSIONS DESPITE NORMAL IN VITRO PLATELET TESTS.

Authors:  J G WHITE; E YUNIS; M COLLIANDER; W KRIVIT
Journal:  Pediatrics       Date:  1964-04       Impact factor: 7.124

6.  LACTOPEROXIDASE. II. ISOLATION.

Authors:  M MORRISON; D E HULTQUIST
Journal:  J Biol Chem       Date:  1963-08       Impact factor: 5.157

7.  Inherited defects of platelet function.

Authors:  M J Stuart
Journal:  Semin Hematol       Date:  1975-07       Impact factor: 3.851

8.  The influence of aspirin and indomethacin on the platelet contractile wave.

Authors:  J M Gerrard; J G White
Journal:  Am J Pathol       Date:  1976-03       Impact factor: 4.307

9.  Clinical and genetic aspects of Glanzmann's thrombasthenia in Israel: report of 22 cases.

Authors:  N Reichert; U Seligsohn; B Ramot
Journal:  Thromb Diath Haemorrh       Date:  1975-12-15

10.  A Ca2+-activated protease possibly involved in myofibrillar protein turnover. Purification from porcine muscle.

Authors:  W R Dayton; D E Goll; M G Zeece; R M Robson; W J Reville
Journal:  Biochemistry       Date:  1976-05-18       Impact factor: 3.162

View more
  67 in total

Review 1.  Platelet glycoprotein IIb/IIIa inhibitors combined with fibrinolytic agents to treat acute myocardial infarction.

Authors:  P L L'Allier; A M Lincoff
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

Review 2.  Platelet surface physiology and its importance in pharmacotherapy design and development: the adenosine diphosphate receptor antagonists.

Authors:  R C Becker
Journal:  J Thromb Thrombolysis       Date:  2000-08       Impact factor: 2.300

Review 3.  Optimal use of platelet glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions.

Authors:  H Benjamin Starnes; Ankit A Patel; George A Stouffer
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

Review 4.  Integrins as therapeutic targets: lessons and opportunities.

Authors:  Dermot Cox; Marian Brennan; Niamh Moran
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

5.  A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.

Authors:  F Lanza; A Stierlé; D Fournier; M Morales; G André; A T Nurden; J P Cazenave
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

6.  Imaging thrombus with radiolabelled monoclonal antibody to platelets.

Authors:  A M Peters; J P Lavender; S G Needham; I Loutfi; D Snook; A A Epenetos; P Lumley; R J Keery; N Hogg
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

7.  Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. Role of the GPIIb amino terminus in integrin subunit association.

Authors:  D A Wilcox; C M Paddock; S Lyman; J C Gill; P J Newman
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 8.  Integrin αIIbβ3: from discovery to efficacious therapeutic target.

Authors:  Kamila Bledzka; Susan S Smyth; Edward F Plow
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

9.  Exposure of platelet fibrinogen receptors by ADP and epinephrine.

Authors:  J S Bennett; G Vilaire
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

10.  Platelet glycoproteins IIb and IIIa: evidence for a family of immunologically and structurally related glycoproteins in mammalian cells.

Authors:  I F Charo; L A Fitzgerald; B Steiner; S C Rall; L S Bekeart; D R Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.